Insulin Pumps Market Size

Insulin Pumps Market Size:

The global insulin pumps market size reached USD 5.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033. The market is driven by the increasing number of people with diabetes, the rising incomes of individuals, the growing awareness about the benefits of the product, and the growing spending on healthcare.

Insulin Pumps Market Analysis:

• Major Market Drivers: The increasing prevalence of diabetes and the growing preference for insulin pump therapy are major market drivers.
• Key Market Trends: Technological advancements in insulin pump devices and rising awareness about the benefits of continuous glucose monitoring integration are insulin pumps market trends.
• Geographical Trends: Growing adoption of insulin pumps in emerging economies and increasing investment in healthcare infrastructure are some of the geographical trends.
• Competitive Landscape: The market is witnessing intensifying competition among key players, leading to product innovations and insulin pumps market recent developments. For instance, Tandem Diabetes Care announced that it has kicked off the U.S. commercial launch of its Mobi insulin patch pump.
• Challenges and Opportunities: Challenges include regulatory hurdles and reimbursement issues, while insulin pumps market opportunities lie in expanding market penetration and developing advanced insulin pump solutions.

Insulin Pumps Market Trends:

Increasing preference for insulin pump therapy

The insulin pumps market analysis shows remarkable growth due to the spike in the usage of insulin pumps. This positive outlook has outdated the traditional method of insulin injection and further improves the quality of life of the individuals. The insulin pumps offer several advantages that have resulted in their growth. The first factor is that insulin pumps offer flexibility and durability, and customizable features as well to cater to the needs and requirements of the public. They enable the patients to keep a check on their diabetic level, reduce the risk of hypoglycemia, and overall improve the living standard of the individuals. Insulin pumps reduce the usage of insulin injections, offering a subtle way of delivering insulin. The patients no longer have to carry the insulin injections with them. Moreover, the integration of continuous glucose monitoring and smartphone devices enabled patients to easily regulate and monitor their glucose levels, improve treatment accuracy, and provide the best solutions. People tend to often use insulin pumps owing to the ongoing awareness in the market. Overall, the insulin pumps have effectively changed the lives of the diabetic patients.

Increasing number of people with diabetes

The insulin pumps provide remedies for treating diabetes and maintaining overall body health. This device regulates glucose levels, reduces the risk of high blood sugar levels, and improves individuals' living standards. Patients often use insulin pumps due to their best features, like durability, flexibility, and convenience. Additionally, the collaboration of the glucose monitoring system with smartphone devices has further enhanced their utility. According to IMARC Group, the insulin pumps market 2021 value reached US$ 2.29 Billion in the United States. As patients are becoming aware of insulin pumps, there is an increased product uptake among consumers, which has positively impacted their growth in the market. As of the current year, the market in the United States is set to experience steady growth at a CAGR rate of 4.0% during 2024-2032. Therefore, government bodies of developed as well as developing countries have come up with several initiatives to improve diabetes management efficiently and has substantially increased diabetes care by promoting the technology of insulin pumps. The market players are continuously investing in research and development to manufacture user-friendly insulin pumps and upgrade them to meet consumer needs.

Rising awareness and education

The insulin pumps market overview shows that the market is driven largely by increased awareness and education regarding diabetes management and treatment options. Since people’s knowledge about diabetes, as well as its complications, is on the rise, it has come to be known that keeping a healthy blood sugar level can make a difference in the outcomes of patients. Education programs offered by health care providers, favorable initiatives from patient advocacy organizations, and marketing campaigns by industry bodies regarding insulin pumps help in debunking perceptions surrounding them, which is encouraging their uptake. Healthcare professionals and patients are now better informed about how effective an insulin pump would be for their blood-sugar control, reducing hypoglycemia risk and making life better for people with diabetes.  Hence, by increasing patients’ knowledge base on diabetes self-care decision-making process through raising awareness and education, there is, therefore, greater acceptance of insulin pump therapy that leads to growth of the market.

Insulin Pumps Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global and regional levels for 2025-2033. Our report has categorized the market based on product type and distribution channel.

Breakup by Product Type:

• Insulin Pumps 
  • Tethered Pumps
  • Disposable/Patch Insulin Pumps
• Insulin Pump Supplies and Accessories
  • Infusion Set Insertion Devices
  • Insulin Reservoirs/Cartridges

Insulin pumps account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product type. This includes insulin pumps (tethered pumps and disposable/patch insulin pumps) and insulin pump supplies and accessories (infusion set insertion devices and insulin reservoirs/cartridges). According to the report, insulin pumps (tethered pumps and disposable/patch insulin pumps) represented the largest segment.

Insulin pumps market growth is driven by the advent of different types of insulin pumps. Tethered pumps use a catheter that is connected to an external device for continuous subcutaneous infusion of insulin. Conversely, disposable or patch insulin pumps are small wearable devices that stick directly onto the skin, thereby offering discrete and convenient ways of administrating insulin without tubes or external equipment. The expansion of the range of options when it comes to the insulin pump enables diabetic individuals to select their desired ones, hence increasing their adoption rate within society while also expanding its reach. Also, increased awareness among patients and healthcare providers, plus technological advancements in the design and functionality of these pumps, has led to a high insulin pumps market demand.

Breakup by Distribution Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Online Sales
• Diabetes Clinics/ Centers
• Others

Hospital pharmacy holds the largest share of the industry

A detailed breakup and analysis of the market based on the distribution channel have also been provided in the report. This includes hospital pharmacy, retail pharmacy, online sales, diabetes clinics/ centers, and others. According to the report, hospital pharmacy accounted for the largest insulin pumps market share.

The market is majorly driven by hospital pharmacies that play a critical role in ensuring proper integration and implementation of this equipment in inpatient treatment pathways. Hospital pharmacists, as major stakeholders in drug management, work closely with healthcare teams to evaluate patients’ needs, optimize therapy plans, and guarantee secure and efficient medication administration. In addition to medical supply procurement, stocking, educating patients as well as follow-up monitoring of the outcomes of the therapies applied through insulin pump support programs by hospital pharmacies. Meanwhile, such aspects are also highlighted in increasing patient acceptance, including training patients on how to use insulin pumps.

Breakup by Region:

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

North America leads the market, accounting for the largest insulin pumps market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Asia Pacific, Europe, Latin America and the Middle East and Africa. According to the report, North America accounted for the largest market share.

A high incidence rate of diabetes, especially type 1 diabetes, leading to a demand for an insulin pump therapy as an effective treatment option is among other factors driving North America’s insulin pumps market statistics. In 2021, 38.4 million Americans had diabetes. Additionally, favorable insurance policies towards reimbursement are coupled with increasing health provision professionals’ knowledge about benefits linked to insulin pumps thereby steering their adoption over time into this area. Moreover, technological advancements in insulin pump technology contribute to growth in insulin pumps market price.

Key Regional Takeaways:

United States Insulin Pumps Market Analysis

The United States has the highest market share in the global insulin pumps market due to the high incidence of diabetes, positive reimbursement strategies, and robust healthcare infrastructure. Innovative technologies like tubeless and auto-insulin delivery systems have supported adoption among both Type 1 and Type 2 diabetics. Market leaders like Medtronic and Insulet Corporation have a stronghold with ongoing innovation and product releases. Increasing awareness of diabetes care, combined with increasing demand for minimally invasive products, sustains market growth. Moreover, partnerships between healthcare professionals and pump companies are improving patient access. Growing pediatric diabetic population and choice of wearable diabetes devices also drive market growth. Nonetheless, restrictive costs and insurance coverage for premium pumps are minor deterrents. Notwithstanding this, the market trend continues to be positive, with insulin therapy conducted at home being increasingly popular after COVID-19. The future direction is likely to be influenced by AI-guided closed-loop systems and interoperability with digital health platforms.

Europe Insulin Pumps Market Analysis

Europe is an important insulin pump market based on a growing diabetic population, robust government efforts, and growing patient awareness of sophisticated diabetes management therapies. Germany, the UK, and France are the front-runners in adoption based on strong healthcare infrastructures and reimbursement policies. Global and regional companies play a role in technological advancements in the form of features like Bluetooth compatibility and continuous glucose monitoring integration. Though expensive to initiate, good policies and early diagnosis campaigns fuel market growth. Furthermore, the transition away from pandemic-era home-based and remote monitoring solutions has further increased demand. Market penetration still varies unevenly within Eastern Europe, though, due to expense and lack of access to healthcare. The region's emphasis on personalized medicine and integration of digital health is indicative of high potential for growth.

Asia Pacific Insulin Pumps Market Analysis

Asia Pacific demonstrates high market potential with an increasing diabetic patient base, particularly in India and China. Increasing healthcare awareness, diabetes care initiatives by the government, and urbanization support market growth. Nevertheless, the high cost of devices and sparse insurance coverage hold back widespread usage. Local competitors are stepping into the market, providing low-cost solutions. Technological advancements and growing usage of telemedicine also favor regional growth.

Latin America Insulin Pumps Market Analysis

Latin America’s insulin pumps market is expanding gradually due to increasing diabetes incidence and healthcare modernization in countries like Brazil and Mexico. Government diabetes awareness programs and improving medical infrastructure support demand. However, high pump costs and limited reimbursement policies slow market penetration. The region holds potential for growth as healthcare access and insurance coverage improve.

Middle East and Africa Insulin Pumps Market Analysis

The Middle East and Africa market remains nascent but is expected to grow due to rising diabetes prevalence, especially in Gulf countries. Government health initiatives and expanding private healthcare sectors drive demand. However, high costs and limited awareness hinder adoption, particularly in Africa. Improved healthcare funding and patient education programs are anticipated to boost market growth in the coming years.

Leading Key Players in the Insulin Pumps Industry:

The key players are taking strategic initiatives to increase their product lines, improve technological innovations, and grow their businesses. These companies are investing in the development of advanced insulin pump technologies to raise insulin pumps market revenue. They are also engaging in marketing activities to raise awareness. They are also taking customer feedback to improve product use and ensure patient satisfaction. The key players are trying hard to spread awareness about the benefits of the pump. They are fostering a culture of innovation and collaboration. They are taking all the efforts to drive insulin pumps market outlook.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• CeQur SA
• F. Hoffmann-La Roche AG
• Jiangsu Delfu medical device Co., Ltd.
• Medtronic plc
• Medzer LLC
• MicroPort Scientific Corporation
• Micro-Tech Medical, Inc.
• SOOIL Developments Co., Ltd.
• Terumo Corporation
• Ypsomed AG

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

• In April 2025, Medtronic submitted 510(k) applications to the FDA for its MiniMed™ 780G ACE insulin pump and SmartGuard™ iAGC algorithm, aiming to enable integration with Abbott's latest continuous glucose monitoring (CGM) platform. This move advances their collaboration announced last August, where Abbott's CGM technology will be exclusively integrated into Medtronic’s smart insulin delivery systems. The partnership offers customers enhanced CGM choices and innovative diabetes management solutions.
• In March 2025, Tandem Diabetes Care launched its new Control-IQ+ automated insulin delivery technology in the U.S., expanding use to people aged 2+ with type 1 diabetes and adults with type 2 diabetes. Compatible with the t\:slim X2 pump and Tandem Mobi System, Control-IQ+ offers enhanced personalization, extended bolus options, and wider insulin delivery parameters. Existing customers can access the upgrade free via remote update, broadening Tandem’s reach in diabetes care solutions.
• May 26, 2023: Medtronic plc announced that it has agreed to acquire EOFlow Co. Ltd., a global producer of insulin delivery devices.
• February 7, 2024: Insulet Corp announced that it had received CE mark approval for the Abbott FreeStyle Libre 2 Plus sensor with Insulet’s Omnipod 5 Automated Insulin Delivery System.
• March 27, 2024: Medtronic plc announced that the FDA has approved the Evolut™ FX+ transcatheter aortic valve replacement (TAVR) system.

Insulin Pumps Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the insulin pumps market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the global insulin pumps market.
• The study maps the leading, as well as the fastest-growing, regional markets.
• Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the insulin pumps industry and its attractiveness.
• The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.